Data suggests that dramatic weight loss, including via GLP-1 drugs, could save Americans big bucks in healthcare spending.
"But at $700 a month, that's not going to happen." Even as weight loss drugs such as Wegovy and Zepbound explode in ...
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular ...